ReviewRegenerative therapy2026
3D bioprinting technologies and biomaterial-based scaffolds for wound healing: Insights into decellularized tissue-derived bioinks.
Review in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The field of tissue engineering has witnessed significant advancements with the advent of 3D printing technologies, especially in wound healing. Innovative 3D-printed scaffolds incorporating decellularized biomaterials offer a promising approach to enhance the regenerative process. Decellularized biomaterials, derived from natural tissues, retain the extracellular matrix (ECM) components crucial for cell adhesion, migration, and tissue regeneration. These biomaterials are processed to remove cellular material, minimizing immune rejection and ensuring biocompatibility. When combined with the precision of 3D printing, these scaffolds can be tailored to match the specific needs of different wound types, promoting effective tissue integration and accelerated healing. This approach provides a platform for the creation of personalized, patient-specific treatments, addressing the limitations of traditional wound care strategies. Furthermore, the ability to print scaffolds with complex structures allows for the optimization of mechanical properties and porosity, facilitating nutrient exchange and cellular infiltration. This paper explores the potential of 3D-printed decellularized biomaterial scaffolds in revolutionizing wound healing, emphasizing their role in improving regenerative outcomes and reducing the risks of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.